ATYR

MODERATE

aTYR PHARMA INC

CIK: 0001339970

Sell (50% confidence)

Last activity: Feb 4, 2026

Financial Metrics

As of Dec 31, 2025 (10-K)

Revenue $235K

Net Income -$74.12M

Total Debt $23.46M

Debt/Equity 0.33

Insider	Sells	Net Value	Holdings
Shukla Sanjay President and CEO	1	-$4K	153,553 shares $150K
Broadfoot Jill Marie Chief Financial Officer	1	-$2K	37,296 shares $36K
DENYES NANCY General Counsel	1	-$1K	33,124 shares $32K

SELL Shukla Sanjay (President and CEO)

3,745 shares @ $0.98

$4K

Feb 4, 2026

Conviction: | View SEC Filing →

SELL Broadfoot Jill Marie (Chief Financial Officer)

1,558 shares @ $0.98

$2K

Feb 4, 2026

Conviction: | View SEC Filing →

SELL DENYES NANCY (General Counsel)

1,118 shares @ $0.98

$1K

Feb 4, 2026

Conviction: | View SEC Filing →

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.